MAPT and Alzheimer disease: SEM also exhibits the ability to alleviate tau pathology in the same hippocampal CA3 region, suggesting a potential influence on the abnormal aggregation or alteration of tau proteins, thereby contributing to the amelioration of AD-related pathological changes [33,36,82,83,84,85,86].